ST. LOUIS–(BUSINESS WIRE)–Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of the assets of BioST. LOUIS–(BUSINESS WIRE)–Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of the assets of Bio

Thompson Street Capital Partners Portfolio Company PestCo Holdings Acquires Bio-Tech Pest Control

2026/01/07 19:34
2분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

ST. LOUIS–(BUSINESS WIRE)–Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of the assets of Bio-Tech Pest Control (Bio-Tech) by PestCo Holdings, LLC (PestCo), a growth-oriented, national provider of pest control services to residential and commercial customers and a TSCP portfolio company. Based in Spring, TX, Bio-Tech is a leading provider of residential and commercial pest control services throughout metropolitan Houston. This acquisition represents a strategic addition in the Houston market, one of the largest and fastest growing cities in the United States. Terms of the transaction were not disclosed.

“We continue to expand our presence in the great state of Texas and are excited about the addition of the Bio-Tech team to the PestCo family. Our goals remain consistent in that we will strive to earn the loyalty of each Bio-Tech customer, while expanding opportunities to PestCo team members across the U.S.,” said Jay Keating, CEO of PestCo.

Pierre Riettini and Jason Pitman, owners of Bio-Tech Pest Control, said, “For over 30 years, we worked hard to build a tremendous company with many great people involved along the way. As hard as it is to let go, we felt that PestCo was the right fit, and this is the right time. We know that PestCo will treat our employees and customers every bit as well as we did, and we’re excited to see where Bio-Tech goes from here.”

“Thompson Street is pleased to support PestCo’s continued expansion in the Houston metropolitan area through the acquisition of Bio-Tech, a well-established and respected player in the region,” said Dan Cooper, Managing Director at TSCP.

About Thompson Street Capital Partners

Thompson Street Capital Partners (tscp.com) is a middle-market private equity firm that helps transform already exceptional businesses into market leaders. Based in St. Louis, Missouri, TSCP invests globally in the life sciences and healthcare, software and technology, business and consumer services and products sectors. TSCP partners with management teams to increase value by accelerating growth, both organically and via complementary acquisitions.

Contacts

Camaryn Sapienza

Gregory

(630) 699-9865

csapienza@gregoryagency.com

시장 기회
BIO Protocol 로고
BIO Protocol 가격(BIO)
$0.01807
$0.01807$0.01807
+2.78%
USD
BIO Protocol (BIO) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!